ISRCTN77241966已完成未知
tility of the Xpert® MTB/RIF Ultra assay with the GeneXpert®Omni System and digital chest radiography for diagnosis of tuberculosis in high HIV prevalence settings: protocol for a randomised control trial
ondon School of Hygiene and Tropical Medicine0 个研究点目标入组 640 人开始时间: 2019年9月2日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 640
研究概览
简要总结
2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35963826/ (added 09/09/2022)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Aged = 18 years
- •2. Having TB symptoms (cough of any duration, fever, night sweats or weight loss)
- •3. Able to submit sputum
- •4. Willing and able to provide informed consent
排除标准
- •1, Presence of clinical danger signs (unable to walk unaided, confused or agitated, breathless when speaking or at rest)
- •2. Already taking TB treatment, or taken TB treatment within the last 60 days
- •3. Unable to submit sputum and refuses offer of sputum induction
- •4. Previously been enrolled in the trial
研究者
相似试验
尚未招募
不适用
Sensitivity and Specificity of Xpert MTB/RIF UltraTuberculosisNCT06058065Assiut University200
已完成
不适用
Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in Pulmonary Tuberculosis SuspectsTuberculosisNCT01587469Cepheid992
已完成
不适用
Xpert for Tuberculosis: Evaluating a New Diagnostic (XTEND)Infections and InfestationsRespiratory tuberculosis, bacteriologically and histologically confirmedTuberculosisISRCTN68905568Bill and Melinda Gates Foundation (USA)4,400
已完成
不适用
TB PCR in BAL and EBUS-TBNATuberculosisNCT04909385Imperial College Healthcare NHS Trust394
进行中（未招募）
不适用
TB-CAPT MTB/XDR StudyResistance BacterialDiagnoses DiseaseTuberculosisNCT04567368Foundation for Innovative New Diagnostics, Switzerland753